搜尋結果
Britain, Australia call for WADA review amid China furore
Reuters· 3 小時前The anti-doping authorities of Britain and Australia have called for a review of WADA's ...
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Reuters· 24 小時前, opens new tab beat Wall Street estimates for first-quarter profit on Wednesday, helped by a ...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 4 小時前AstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer ...
Plaintiffs' lawyers chosen to lead Ozempic litigation
Reuters· 15 小時前, opens new tab failed to warn of the risks of harsh side effects associated with blockbuster ...
Walgreens To Launch $24 Billion Business Dedicated To Specialty Pharmacy
Forbes· 6 小時前Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates new ...
Sanofi Q1 profit slips on generic competition, forex effects
Reuters· 5 小時前Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable ...
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
Reuters· 14 小時前Committee on Health, Education, Labor and Pensions, sent a letter to Novo's CEO seeking ...
Pharma Startup Uses AI to Test Old Drugs to Treat Rare Diseases
Bloomberg· 23 小時前Transcripta Bio’s AI software analyzes rare diseases to see if existing pharmaceuticals can ...
Sanofi Sales, Profit Beat Expectations
The Wall Street Journal· 3 小時前Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of ...
Indivior Confirms Plan to Switch Listing From London to New York
Bloomberg· 3 小時前Indivior Plc has confirmed plans to switch its primary listing to New York this summer, and ...